clinicalintelpulse.vercel.app
Route probed: GET https://clinicalintelpulse.vercel.app/api/clinical/deal-signal
Category: eat:gov/regulatory/product (tags: health, people, gov-data, content, geo, data-tools) · Status: listing listed, probe active · Listing: 0.35 USD, 0 payers / 0 calls (30d, Bazaar) · Listed in: agentic-market
Last probe: 2026-10-23T16:58:13Z (26 min ago) · Recent valid 402: 2/2 · p50 1186 ms
probe-only: no paid test-buys yet. No index until 3 paid buys on 3 different days.
Badge: 
Paid test-buys
None yet.
402 challenge checks (since 2026-10-23T16:58:13Z)
1 valid 402s checked: terms consistent 0, Base USDC offered 1, price matches listing 1 (differs 0), payTo changed vs previous probe 0.
Unpaid probes (newest first, up to 200; raw receipts are kept 7 days, then in the archive)
| Receipt | UTC time | Method | Status | Valid 402 | ms | Listed amount (atomic) | Quoted amount (atomic) | Quoted payTo | Header bytes | Response sha256 | Signed | Route | Checks |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 517d85c515447fb10719 | 2026-10-23T16:58:13Z | GET | 402 | yes | 1186 | 350000 | 350000 | 0x50ab2018… | 12800 | 7ebec1e80e81aff1 | per-receipt | primary | header_body_terms_differ option_amount_not_integer resource_host_differs · Base USDC |
| 2dd0c1895da350c3f976 | 2026-10-23T12:45:47Z | GET | 402 | yes | 236 | 350000 | 350000 | 0x50ab2018… | 12800 | 7ebec1e80e81aff1 | snapshot | primary |
Other listed routes
GET https://clinicalintelpulse.vercel.app/api/clinical/deal-signalBiotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, tr (agentic-market)GET https://clinicalintelpulse.vercel.app/api/clinical/trial-briefClinical trial deep dive by NCT ID — full trial design, primary/secondary endpoints, enrollment status and countries, sponsor, recruitment criteria, outcomes an (agentic-market)GET https://clinicalintelpulse.vercel.app/api/clinical/global-trialsGlobal clinical trial landscape for any disease — geographic distribution by country across WHO ICTRP registries (US, EU, China, India, Japan, Brazil, Africa an (agentic-market)GET https://clinicalintelpulse.vercel.app/api/clinical/mechanism-mapDrug mechanism-of-action + molecular target landscape for any disease — targets in active trials, approved agents by MOA, crowded vs novel mechanisms and first- (agentic-market)GET https://clinicalintelpulse.vercel.app/api/clinical/pipeline-scanClinical trial pipeline scan for any disease — all active Phase 2/3 trials with trial counts, sponsor landscape, geographic distribution, mechanism breakdown an (agentic-market)GET https://clinicalintelpulse.vercel.app/api/clinical/sponsor-intelPharma/biotech company pipeline intelligence — full drug pipeline by phase, therapeutic-area coverage, FDA approval history, partnerships, competitive positioni (agentic-market)GET https://clinicalintelpulse.vercel.app/api/clinical/patient-finderRecruiting clinical trial finder for a disease or diagnosis — actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), count (agentic-market)GET https://clinicalintelpulse.vercel.app/api/clinical/approval-outlookFDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, tri (agentic-market)GET https://clinicalintelpulse.vercel.app/api/clinical/failure-analysisClinical trial failure analysis for a disease area — why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy wi (agentic-market)GET https://clinicalintelpulse.vercel.app/api/clinical/disease-landscapeCompetitive drug pipeline landscape for any disease — full Phase 2/3 trial map, mechanism-of-action coverage, approved drugs, PDUFA calendar, M&A activity, oppo (agentic-market)
Seller? Reply or dispute. Amounts are in the asset's atomic units (USDC: 6 decimals).